Our work is deeply rooted in clinical research
Teal is built on scientific integrity, backed by rigorous clinical trials, peer-reviewed publications, and premier medical presentations.
Teal Research
The HeLa and SiHa Cell Lines: Recognizing a History of Harm to Envision a Future Without Cervical Cancer
Part 3: Lessons in Equity: The Promising Potential of Self-Collection to End Cervical Cancer
Why Self-Collected HPV Tests are a Critical Pathway to Ending Cervical Cancer in the United States (A Three-Part Series)
Some of the clinicians behind the data
Principal investigators and senior advisors who participated in the trial and authored resulting publications.
Christine Conageski, MD, MSc
Ann S. Collins, MD, FACOG
Elizabeth Sutton, PhD
Woman's Hospital
Ronald W. Orso, MD
Birmingham Obstetrics &
Gynecology, P.C.
Catherine Behrens, MD, PhD, FACOG
Emeline Aviki, MD, MBA
Sangini S. Sheth, MD, MPH,FACOG
Summer Dewdney, MD
16 SITES
PRIMARY HPV
CIN2+ MEASURED
Prospective, method-comparison trial
16 US academic & community centers
600+ women, ages 25–65. Diverse in age, race, & screening history
Roche cobas® HPV
Paired clinician collection, same visit
Complete · published 2025
SELF-CERV clinical trial
The results from the SELF-CERV trial supported the FDA-authorization of the Teal Wand. It compared self-collection with the Teal Wand to a clinician-collected sample taken at the same visit, with both samples analyzed on the same FDA-approved primary HPV test.
The trial, covered.
Screen for cervical cancer, without the speculum.
Self-collect at home and mail to the lab for Primary HPV testing, on your timeline, with results reviewed and shared by a Teal Medical provider.
